开云app官网登录入口网页版-官方正版

#ASC#

1352篇内容 | 6301人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939498, encodeId=cae31939498f6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：连续血糖监测在心血管高危糖尿病患者中的作用, objectType=article, longId=739437, objectId=f180e3943747, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f180e3943747, replyNumber=0, likeNumber=95, createdTime=2023-01-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f180e3943747, moduleTitle=Cardiovasc Diabetol ：连续血糖监测在心血管高危糖尿病患者中的作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f180e3943747)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939493, encodeId=9596193949343, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：2型糖尿病降糖药物和心血管转归的时间分辨轨迹, objectType=article, longId=739208, objectId=12d6e39208fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12d6e39208fb, replyNumber=0, likeNumber=0, createdTime=2023-08-01, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12d6e39208fb, moduleTitle=Cardiovasc Diabetol ：2型糖尿病降糖药物和心血管转归的时间分辨轨迹, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=12d6e39208fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939488, encodeId=647919394883f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：尿中微生物酚类代谢物的一年变化与2型糖尿病风险的关系, objectType=article, longId=737621, objectId=4001e376217a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4001e376217a, replyNumber=0, likeNumber=104, createdTime=2022-09-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4001e376217a, moduleTitle=Cardiovasc Diabetol：尿中微生物酚类代谢物的一年变化与2型糖尿病风险的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4001e376217a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939489, encodeId=1d00193948918, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响, objectType=article, longId=737622, objectId=1a68e376228d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a68e376228d, replyNumber=0, likeNumber=93, createdTime=2023-03-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a68e376228d, moduleTitle=Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1a68e376228d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939471, encodeId=b35c19394e1fb, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=治疗时这3件事，你都做对了吗？ASCO权威解答来了：首个癌症治疗期间生活方式指南！, objectType=article, longId=734759, objectId=3627e3475938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3627e3475938, replyNumber=0, likeNumber=102, createdTime=2022-12-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3627e3475938, moduleTitle=治疗时这3件事，你都做对了吗？ASCO权威解答来了：首个癌症治疗期间生活方式指南！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3627e3475938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939494, encodeId=6bbc1939494d8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol:1型糖尿病患者的HDL功能:血糖控制改善后胆固醇流出能力增强与高密度脂蛋白氨基甲酰化降低相关, objectType=article, longId=739202, objectId=f699e39202bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f699e39202bf, replyNumber=0, likeNumber=102, createdTime=2022-11-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f699e39202bf, moduleTitle=Cardiovasc Diabetol:1型糖尿病患者的HDL功能:血糖控制改善后胆固醇流出能力增强与高密度脂蛋白氨基甲酰化降低相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f699e39202bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939465, encodeId=3e6b1939465fa, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病（ASCVD）风险评分的影响 , objectType=article, longId=733948, objectId=a522e33948a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a522e33948a6, replyNumber=0, likeNumber=85, createdTime=2023-06-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a522e33948a6, moduleTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病（ASCVD）风险评分的影响 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a522e33948a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939477, encodeId=21c119394e71f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：卡格列净治疗可显著改善T2DM+心衰患者的心衰状态, objectType=article, longId=735659, objectId=3e72e35659a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e72e35659a1, replyNumber=0, likeNumber=124, createdTime=2022-12-23, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e72e35659a1, moduleTitle=Cardiovasc Diabetol：卡格列净治疗可显著改善T2DM+心衰患者的心衰状态, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3e72e35659a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939455, encodeId=f31619394555d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：血管活性肽CT-proET-1和MR-proADM与2型糖尿病事件的相关性, objectType=article, longId=731467, objectId=9b26e314670f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b26e314670f, replyNumber=0, likeNumber=97, createdTime=2022-08-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b26e314670f, moduleTitle=Cardiovasc Diabetol ：血管活性肽CT-proET-1和MR-proADM与2型糖尿病事件的相关性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b26e314670f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939483, encodeId=b994193948330, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Front Cardiovasc Med：左心衰竭所致肺动脉高压的患病率和生存率, objectType=article, longId=736466, objectId=a5a6e36466da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5a6e36466da, replyNumber=0, likeNumber=91, createdTime=2023-02-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5a6e36466da, moduleTitle=Front Cardiovasc Med：左心衰竭所致肺动脉高压的患病率和生存率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a5a6e36466da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939452, encodeId=224a19394525b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数与普通人心血管疾病及死亡风险的相关性, objectType=article, longId=731145, objectId=62b6e3114589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62b6e3114589, replyNumber=0, likeNumber=104, createdTime=2023-01-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62b6e3114589, moduleTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数与普通人心血管疾病及死亡风险的相关性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=62b6e3114589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939379, encodeId=9c0519393e9f4, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, objectType=article, longId=728445, objectId=f96ae28445fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96ae28445fc, replyNumber=0, likeNumber=106, createdTime=2022-08-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96ae28445fc, moduleTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f96ae28445fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939385, encodeId=1cfc1939385a1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物, objectType=article, longId=728229, objectId=e1ace28229dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ace28229dc, replyNumber=0, likeNumber=98, createdTime=2022-11-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ace28229dc, moduleTitle=ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e1ace28229dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939373, encodeId=528519393e344, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：这些临床特征与晚期非小细胞肺癌患者的功能恢复能力有关, objectType=article, longId=728264, objectId=993de28264a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993de28264a3, replyNumber=0, likeNumber=95, createdTime=2022-06-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993de28264a3, moduleTitle=2022 ASCO：这些临床特征与晚期非小细胞肺癌患者的功能恢复能力有关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=993de28264a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939458, encodeId=bc9f193945838, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：除低密度脂蛋白胆固醇外的残余胆固醇在糖尿病中的作用, objectType=article, longId=732036, objectId=7d8fe3203646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d8fe3203646, replyNumber=0, likeNumber=108, createdTime=2023-04-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d8fe3203646, moduleTitle=Cardiovasc Diabetol：除低密度脂蛋白胆固醇外的残余胆固醇在糖尿病中的作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7d8fe3203646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939469, encodeId=45ea1939469cd, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Cardiovasc Electrophysiol：老年房颤患者选择消融术治疗似乎也是安全的, objectType=article, longId=733917, objectId=15bae33917f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15bae33917f9, replyNumber=0, likeNumber=106, createdTime=2023-06-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15bae33917f9, moduleTitle=J Cardiovasc Electrophysiol：老年房颤患者选择消融术治疗似乎也是安全的, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=15bae33917f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939387, encodeId=e808193938eaf, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 幽门螺杆菌感染与胰腺癌之间呈正相关, objectType=article, longId=728454, objectId=e571e2845404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e571e2845404, replyNumber=0, likeNumber=104, createdTime=2023-01-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e571e2845404, moduleTitle=ASCO 2022 | 幽门螺杆菌感染与胰腺癌之间呈正相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e571e2845404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939406, encodeId=206e1939406a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, objectType=article, longId=728269, objectId=0f7ce282691b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f7ce282691b, replyNumber=0, likeNumber=96, createdTime=2022-12-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f7ce282691b, moduleTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0f7ce282691b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939353, encodeId=31ef1939353aa, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, objectType=article, longId=727305, objectId=fc4be2730555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4be2730555, replyNumber=0, likeNumber=75, createdTime=2022-09-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4be2730555, moduleTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fc4be2730555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939491, encodeId=f856193949151, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：空腹甘油三酯水平与2型糖尿病发病率的关系, objectType=article, longId=737623, objectId=6787e3762305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6787e3762305, replyNumber=0, likeNumber=79, createdTime=2023-01-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6787e3762305, moduleTitle=Cardiovasc Diabetol：空腹甘油三酯水平与2型糖尿病发病率的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6787e3762305)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：连续血糖监测在心血管高危糖尿病患者中的作用

2023-01-05

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：2型糖尿病降糖药物和心血管转归的时间分辨轨迹

2023-08-01

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：尿中微生物酚类代谢物的一年变化与2型糖尿病风险的关系

2022-09-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响

2023-03-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

治疗时这3件事，你都做对了吗？ASCO权威解答来了：首个癌症治疗期间生活方式指南！

2022-12-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol:1型糖尿病患者的HDL功能:血糖控制改善后胆固醇流出能力增强与高密度脂蛋白氨基甲酰化降低相关

2022-11-04

quxin068 (审核中...)

前往app查看评论内容

#ASC#

PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病（ASCVD）风险评分的影响

2023-06-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：卡格列净治疗可显著改善T2DM+心衰患者的心衰状态

2022-12-23

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：血管活性肽CT-proET-1和MR-proADM与2型糖尿病事件的相关性

2022-08-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Front Cardiovasc Med：左心衰竭所致肺动脉高压的患病率和生存率

2023-02-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：甘油三酯-葡萄糖指数与普通人心血管疾病及死亡风险的相关性

2023-01-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素

2022-08-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：四周的MPRbx可作为晚期黑色素瘤治疗反应的早期生物标志物

2022-11-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：这些临床特征与晚期非小细胞肺癌患者的功能恢复能力有关

2022-06-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：除低密度脂蛋白胆固醇外的残余胆固醇在糖尿病中的作用

2023-04-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Cardiovasc Electrophysiol：老年房颤患者选择消融术治疗似乎也是安全的

2023-06-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 幽门螺杆菌感染与胰腺癌之间呈正相关

2023-01-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系

2022-12-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响

2022-09-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：空腹甘油三酯水平与2型糖尿病发病率的关系

2023-01-24

科室
- - 订阅+
  - 更多科室
工具
服务